MEDNAX

NYSE MD
$7.74 -0.05 -0.65%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 19 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

644.55M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.22B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

2.17
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

83.28M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-16.77 %

Upcoming events MEDNAX

All events
No upcoming events scheduled

Stock chart MEDNAX

Stock analysis MEDNAX

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-12.47 19.11
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

0.76 2.10
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

31.11 10.47
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

14.66 2.24
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-6.04 10.15

Price change MEDNAX per year

12.47$ 35.67$
Min Max

Summary analysis MEDNAX

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure MEDNAX

Revenue and net income MEDNAX

All parameters

About company MEDNAX

MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of March 16, 2021, it operated a network of approximately 2,300 physicians. The company was founded in 1979 and is based in Sunrise, Florida.
Address:
1301 Concord Terrace, Sunrise, FL, United States, 33323
Company name: MEDNAX
Issuer ticker: MD
ISIN: US58502B1061
Country: USA
Exchange: NYSE
Currency: $
IPO date: 1995-09-19
Sector: Healthcare
Industry: Health Care Providers & Services
Site: https://www.mednax.com

On which stock exchange are MEDNAX (MD) stocks traded?

MEDNAX (MD) stocks are traded on NYSE.

What is the ticker of MEDNAX stocks (MD)?

The stock ticker of MEDNAX’s stocks or in other words, the code is MD. The stocks are currently listed on the NYSE exchange.

In which sector and industry does MEDNAX (MD) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, MEDNAX (MD) belongs to the «Healthcare» sector and the «Health Care Providers & Services» industry.

In what currency are MEDNAX (MD) stocks traded?

MEDNAX (MD) stocks are traded on the NYSE exchange in dollars.

What is the price of MEDNAX (MD) stocks today?

The current price of MEDNAX stocks on 19.05.2024 is 7.74 dollars. per share.

What is the dynamics of MEDNAX (MD) stocks from the beginning of the year?

MEDNAX (MD) quotes have increased by -17.48% from the beginning of the year up to 7.74 dollars. per 1 stocks.

How much did MEDNAX (MD) stocks increase in мае 2024?

This month MEDNAX (MD) quotes have increased by -14.1% to 7.74 dollars. per share.

How much are MEDNAX (MD) stocks worth?

Today, on October, 19.05.2024 MEDNAX’s (MD) stocks cost 7.74 dollars..

What is the market capitalization of MEDNAX (MD)?

Capitalization is the market value of MEDNAX (MD) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 19.05.2024, the market capitalization of MEDNAX (MD) is estimated at about 644548500 dollars.